Form EFFECT Clearmind Medicine Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 |
| Accession Number: | 0001213900-26-008228 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearmind completes Part A of FDA-regulated AUD drug trial
- Kazakhstan Joins Pax Silica and AI Opportunity Partnership to Advance Trusted AI Infrastructure and Innovation
- Top 3 Cryptos to Buy Now as Pepeto Presale Draws Smart Money During Market Panic
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
